Fresh Recalls

FDAClass II · Drug · Recall D-0609-2026 · Recalled July 1, 2026

Carton Label recall — The Harvard Drug Group LLC

Agency report date: July 1, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Carton Label
Company / brand
The Harvard Drug Group
Lot / serial / date codes
Lots: N02327, expires: 09/2026; N02740, expires: 12/2026; N03069, expires: 08/2027.
Distribution
U.S. Nationwide.
Agency product description and boundaries

Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Subpotent Drug

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Carton Label

3. Open the official notice or contact

Official recall ID
D-0609-2026
Brand
The Harvard Drug Group
Classification
Class II
Units affected
790 Cartons.
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Dublin, OH, United States
Firm address
7000 Cardinal Pl, N/A, 43017-1091

Identifying details (verbatim from the notice)

Product codes / lots
Lots: N02327, expires: 09/2026; N02740, expires: 12/2026; N03069, expires: 08/2027.
Distribution
U.S. Nationwide.
Firm notified the public via
Letter
FDA event ID
99240
Recall initiated
June 16, 2026
FDA classified
June 22, 2026
FDA report date
July 1, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page